These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Halstead SB, Casals J, Shotwell H, Palumbo N. Am J Trop Med Hyg; 1973 May; 22(3):365-74. PubMed ID: 4196288 [No Abstract] [Full Text] [Related]
3. Blood value changes in flavivirus-inoculated Macaca fascicularis monkeys. Angsubhakorn S, Yoksan S, Henchal EA, Nisalak A, Hoke CH, Pradermwong A, Sahaphong S, Bhamarapravati N. Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):1-7. PubMed ID: 2874612 [Abstract] [Full Text] [Related]
4. Studies on the sequential immunization against group B arboviruses in squirrel monkeys, cynomolgus monkeys, rhesus monkeys, and chimpanzees. Price WH, Casals J, O'Leary W. Am J Trop Med Hyg; 1974 Jan; 23(1):118-30. PubMed ID: 4204022 [No Abstract] [Full Text] [Related]
5. Dengue type 3 infection in Panama. Rosen L. Am J Trop Med Hyg; 1974 Nov; 23(6):1205-6. PubMed ID: 4429191 [No Abstract] [Full Text] [Related]
7. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate). Price WH, Casals J, Thind I, O'Leary W. Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231 [No Abstract] [Full Text] [Related]
8. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. Sun W, Nisalak A, Gettayacamin M, Eckels KH, Putnak JR, Vaughn DW, Innis BL, Thomas SJ, Endy TP. J Infect Dis; 2006 Jun 15; 193(12):1658-65. PubMed ID: 16703509 [Abstract] [Full Text] [Related]
13. Dengue virus cross-reactive hemagglutination inhibition antibody responses in patients with primary dengue virus infection. Anantapreecha S, A-Nuegoonpipat A, Prakrong S, Chanama S, Sa-Ngasang A, Sawanpanyalert P, Kurane I. Jpn J Infect Dis; 2007 Sep 15; 60(5):267-70. PubMed ID: 17881865 [Abstract] [Full Text] [Related]
14. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. Halstead SB, Shotwell H, Casals J. J Infect Dis; 1973 Jul 15; 128(1):15-22. PubMed ID: 4198024 [No Abstract] [Full Text] [Related]
15. Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys. Angsubhakorn S, Yoksan S, Bhamarapravati N, Moe JB, Marchette NJ, Pradermwong A, Sahaphong S. Trans R Soc Trop Med Hyg; 1988 Jul 15; 82(5):746-9. PubMed ID: 3252595 [Abstract] [Full Text] [Related]
18. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. Guirakhoo F, Weltzin R, Chambers TJ, Zhang ZX, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP. J Virol; 2000 Jun 15; 74(12):5477-85. PubMed ID: 10823852 [Abstract] [Full Text] [Related]
19. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. Blaney JE, Matro JM, Murphy BR, Whitehead SS. J Virol; 2005 May 15; 79(9):5516-28. PubMed ID: 15827166 [Abstract] [Full Text] [Related]